The Asia Pacific Protein Chip Market is expected to witness market growth of 10.56% CAGR during the forecast period (2021-2027).
Functional Protein Chip Markets and analytical Protein Chip Markets are the two kinds of Protein Chip Markets available in the market. Functional Protein Chip Markets are made of arrays including full-length functional proteins or protein domains, which differs from analytical chips. In addition, these chips are utilized to study the biochemical activities of the whole proteome in one experiment. Also, functional Protein Chip Markets are utilized to study various protein interactions like protein–DNA, protein-protein, protein–phospholipid, protein–RNA, and protein-small molecule interactions.
The cases of cancers in the developing nations of the region like India and China have increased in the last few years, which are creating the demand for better and advanced diagnostic solutions in the regional market. In addition, the high investment of the companies and governments in research and development activities is estimated to spur the growth of the regional Protein Chip Market over the forecast period.
Various nations of this region were severely hit by the COVID-19 pandemic, which has created more demand for these chips in the region as they were used to develop solutions for treating the infected people.
The China market dominated the Asia Pacific Protein Chip Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $81.7 million by 2027. The Japan market is poised to grow at a CAGR of 11.5% during (2021 - 2027). Additionally, The India market is expected to register a CAGR of 11.6% during (2021 - 2027).
Based on End User, the market is segmented into Pharmaceuticals and Biotechnology Sector, Academic & Research Institutes, Diagnostic Laboratories and Hospitals and Clinics. Based on Technology, the market is segmented into Analytical Microarrays, Functional Protein Microarrays and Reverse Phase Protein Microarrays. Based on Application, the market is segmented into Diagnostics, Proteomics and Antibody Characterization. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., RayBiotech Life, Inc., Quotient limited, Danaher Corporation, Arrayit Corporation, Merck Group, and Illumina, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Pharmaceuticals and Biotechnology Sector
- Academic & Research Institutes
- Diagnostic Laboratories and
- Hospitals and Clinics
By Technology
- Analytical Microarrays
- Functional Protein Microarrays and
- Reverse Phase Protein Microarrays
By Application
- Diagnostics
- Proteomics and
- Antibody Characterization
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- RayBiotech Life, Inc.
- Quotient limited
- Danaher Corporation
- Arrayit Corporation
- Merck Group
- Illumina, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- RayBiotech Life, Inc.
- Quotient limited
- Danaher Corporation
- Arrayit Corporation
- Merck Group
- Illumina, Inc.
Methodology
LOADING...
